3 completed, 1 terminated, 1 unknown. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow Phobic Disorders: new trials by email Literature Review of Phobic Disorders trials Research Report on Phobic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol Effects on Fear Extinction in Social Phobia Fear extinction, Cannabidiol Cap/Tab, Placebo - Social Anxiety Disorder | Early Phase 1 | Unknown | Hartford Hospital | 20 | 2024-04-30 | 2024-04-19 |
| Radical Openness for Adolescents Pilot Radically Open Dialectical Behavior Therapy (RO DBT) - Anorexia Nervosa, Obsessive-Compulsive Disorder | Early Phase 1 | Completed | Washington University School of Medicine | 61 | 2020-08-11 | 2023-06-22 |
| Ketamine Infusion for Social Anxiety Disorder Ketamine, Saline - Social Anxiety Disorder | Early Phase 1 | Completed | Yale University | 18 | 2015-01-02 | 2021-03-18 |
| Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder D-Cycloserine, Placebo, Cognitive Behavioral Therapy - Social Anxiety Disorder | Early Phase 1 | Completed | Jasper A. Smits | 152 | 2014-04-01 | 2026-06-15 |
| An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR) Quetiapine XR, Placebo - Social Anxiety Disorder | Early Phase 1 | Terminated | Duke University | 55 | 2008-01-01 | 2014-08-01 |
Phobia, Social (5) · Anorexia Nervosa (1) · Anxiety Disorders (1) · Depression (1) · Obsessive-Compulsive Disorder (1)
Mental Disorders (5) · Anxiety Disorders (4) · Behavior (1) · Behavioral Symptoms (1) · Feeding and Eating Disorders (1)
Cognitive Behavioral Therapy (1) · Cycloserine (1) · Ketamine (1) · Sodium Chloride (1)
Duke University (1) · Hartford Hospital (1) · Jasper A. Smits (1) · Washington University School of Medicine (1) · Yale University (1)
United States (5)
David Tolin, Ph.D. (1) · Jasper A Smits, Ph.D. (1) · Mark Pollack, M.D. (1) · Michael H. Bloch, MD, MS (1) · Stefan Hofmann, Ph.D. (1) · Wei Zhang, MD (1)
PMID 26111923, PMID 28849779, PMID 31622374, PMID 32496566, PMID 34010494, PMID 37399757, PMID 37979218